Market Research Logo

Reproductive Hormones and Proteins Tests - Medical Devices Pipeline Assessment, 2018

Reproductive Hormones and Proteins Tests - Medical Devices Pipeline Assessment, 2018

Summary

GlobalData's Medical Devices sector report, “Reproductive Hormones and Proteins Tests - Medical Devices Pipeline Assessment, 2018 provides an overview of Reproductive Hormones and Proteins Tests currently in pipeline stage.

The report provides comprehensive information on the pipeline products with comparative analysis of the products at various stages of development. The report reviews major players involved in the pipeline product development. It also provides information about clinical trials in progress, which includes trial phase, trial status, trial start and end dates, and, the number of trials for the key Reproductive Hormones and Proteins Tests pipeline products.

This report is prepared using data sourced from in-house databases, secondary and primary research by GlobalData's team of industry experts.

*Note: Certain sections in the report may be removed or altered based on the availability and relevance of data in relation to the equipment type.

Scope

  • Extensive coverage of the Reproductive Hormones and Proteins Tests under development
  • The report reviews details of major pipeline products which includes, product description, licensing and collaboration details and other developmental activities
  • The report reviews the major players involved in the development of Reproductive Hormones and Proteins Tests and list all their pipeline projects
  • The coverage of pipeline products based on various stages of development ranging from Early Development to Approved / Issued stage
  • The report provides key clinical trial data of ongoing trials specific to pipeline products
  • Recent developments in the segment / industry.
Reasons to buy

The report enables you to -
  • Formulate significant competitor information, analysis, and insights to improve R&D strategies
  • Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage
  • Identify and understand important and diverse types of Reproductive Hormones and Proteins Tests under development
  • Develop market-entry and market expansion strategies
  • Plan mergers and acquisitions effectively by identifying major players with the most promising pipeline
  • In-depth analysis of the product’s current stage of development, territory and estimated launch date.


1 Table of Contents
1.1 List of Tables
1.2 List of Figures
2 Introduction
2.1 Reproductive Hormones and Proteins Tests Overview
3 Products under Development
3.1 Reproductive Hormones and Proteins Tests - Pipeline Products by Stage of Development
3.2 Reproductive Hormones and Proteins Tests - Pipeline Products by Segment
3.3 Reproductive Hormones and Proteins Tests - Pipeline Products by Territory
3.4 Reproductive Hormones and Proteins Tests - Pipeline Products by Regulatory Path
3.5 Reproductive Hormones and Proteins Tests - Pipeline Products by Estimated Approval Date
4 Reproductive Hormones and Proteins Tests - Pipeline Products under Development by Companies
4.1 Reproductive Hormones and Proteins Tests Companies - Pipeline Products by Stage of Development
4.2 Reproductive Hormones and Proteins Tests - Pipeline Products by Stage of Development
5 Reproductive Hormones and Proteins Tests Companies and Product Overview
5.1 AgPlus Diagnostics LTD Company Overview
5.2 Albert Einstein College of Medicine Company Overview
5.3 Aura Biotechnologies Pvt Ltd Company Overview
5.4 Beckman Coulter Inc Company Overview
5.5 Boditech Med Inc Company Overview
5.6 China Medical Technologies Inc (Inactive) Company Overview
5.7 DiaSorin SpA Company Overview
5.8 Ellume Company Overview
5.9 Fujirebio Diagnostics Inc Company Overview
5.10 Genovum Sp. z o.o. Company Overview
5.11 Hebrew University of Jerusalem Company Overview
5.12 Immunodiagnostic Systems Holdings plc Company Overview
5.13 King's College London Company Overview
5.14 Labsystems Diagnostics Oy Company Overview
5.15 Lucine Biotechnology, Inc. Company Overview
5.16 Mindray Medical International Ltd Company Overview
5.17 Northwestern University Company Overview
5.18 Oasis Diagnostics Corp Company Overview
5.19 Orangelife Company Overview
5.20 Paramedical Srl Company Overview
5.21 PerkinElmer Inc Company Overview
5.22 Proteomika Company Overview
5.23 QuickCheck Health Inc Company Overview
5.24 Roche Diagnostics International Ltd Company Overview
5.25 Shahid Beheshti University Company Overview
5.26 Siemens Healthcare GmbH Company Overview
5.27 SomaLogic Inc Company Overview
5.28 Swan Diagnostics Ltd Company Overview
5.29 Sysmex Corp Company Overview
5.30 Tecan Group Ltd Company Overview
5.31 Thermo Fisher Scientific Inc Company Overview
5.32 University of Edinburgh Company Overview
5.33 University of Otago Company Overview
6 Reproductive Hormones and Proteins Tests- Recent Developments
6.1 Jun 21, 2018: Sera Prognostics Appoints Dr. Garrett K. Lam as Chief Medical Officer
6.2 Jun 20, 2018: Immunodiagnostic Systems: Final Results for year ended 31 March 2018
6.3 Jun 19, 2018: Sera Prognostics Collaborates with Christiana Care Health System to Launch New Preterm Birth Study with PreTRM Test
6.4 Jun 12, 2018: Change at the top of the Segment Advanced Therapies at Siemens Healthineers
6.5 Jun 07, 2018: Blood test may identify pregnant women at risk of premature birth
7 Appendix
7.1 Methodology
7.2 About GlobalData
7.3 Contact Us
7.4 Disclaimer
1.1 List of Tables
Table 1: Reproductive Hormones and Proteins Tests - Pipeline Products by Stage of Development
Table 2: Reproductive Hormones and Proteins Tests - Pipeline Products by Segment
Table 3: Reproductive Hormones and Proteins Tests - Pipeline Products by Territory
Table 4: Reproductive Hormones and Proteins Tests - Pipeline Products by Regulatory Path
Table 5: Reproductive Hormones and Proteins Tests - Pipeline Products by Estimated Approval Date
Table 6: Reproductive Hormones and Proteins Tests Companies - Pipeline Products by Stage of Development
Table 7: Reproductive Hormones and Proteins Tests - Pipeline Products by Stage of Development
Table 8: AgPlus Diagnostics LTD Pipeline Products & Ongoing Clinical Trials Overview
Table 9: AgPlus Diagnostic System - Testosterone Assay - Product Status
Table 10: AgPlus Diagnostic System - Testosterone Assay - Product Description
Table 11: Albert Einstein College of Medicine Pipeline Products & Ongoing Clinical Trials Overview
Table 12: Estradiol Assay - Product Status
Table 13: Estradiol Assay - Product Description
Table 14: Aura Biotechnologies Pvt Ltd Pipeline Products & Ongoing Clinical Trials Overview
Table 15: AURA Quant Anti-Mullerian hormone (AMH) ELISA Kit - Product Status
Table 16: AURA Quant Anti-Mullerian hormone (AMH) ELISA Kit - Product Description
Table 17: Beckman Coulter Inc Pipeline Products & Ongoing Clinical Trials Overview
Table 18: Access 2 Immunoassay System - Sensitive Estradiol - Product Status
Table 19: Access 2 Immunoassay System - Sensitive Estradiol - Product Description
Table 20: UniCel DxC 660i Synchron Access Clinical System - AMH Assay - Product Status
Table 21: UniCel DxC 660i Synchron Access Clinical System - AMH Assay - Product Description
Table 22: UniCel DxI 600 Access Immunoassay System - AMH Assay - Product Status
Table 23: UniCel DxI 600 Access Immunoassay System - AMH Assay - Product Description
Table 24: UniCel DxI 600 Access Immunoassay System - Sensitive Estradiol Assay - Product Status
Table 25: UniCel DxI 600 Access Immunoassay System - Sensitive Estradiol Assay - Product Description
Table 26: UniCel DxI 800 Access Immunoassay System - AMH Assay - Product Status
Table 27: UniCel DxI 800 Access Immunoassay System - AMH Assay - Product Description
Table 28: UniCel DxI 800 Access Immunoassay System - Sensitive Estradiol Assay - Product Status
Table 29: UniCel DxI 800 Access Immunoassay System - Sensitive Estradiol Assay - Product Description
Table 30: Boditech Med Inc Pipeline Products & Ongoing Clinical Trials Overview
Table 31: AFIAS-6 Progesterone Assay - Product Status
Table 32: AFIAS-6 Progesterone Assay - Product Description
Table 33: China Medical Technologies Inc (Inactive) Pipeline Products & Ongoing Clinical Trials Overview
Table 34: Infertility Reagent Test kit - ECLIA Analyzer - Product Status
Table 35: Infertility Reagent Test kit - ECLIA Analyzer - Product Description
Table 36: DiaSorin SpA Pipeline Products & Ongoing Clinical Trials Overview
Table 37: Estradiol II Assay - Product Status
Table 38: Estradiol II Assay - Product Description
Table 39: Progesterone II Assay - Product Status
Table 40: Progesterone II Assay - Product Description
Table 41: Ellume Pipeline Products & Ongoing Clinical Trials Overview
Table 42: ESP-Based Diagnostic Test - Pregnancy - Product Status
Table 43: ESP-Based Diagnostic Test - Pregnancy - Product Description
Table 44: Fujirebio Diagnostics Inc Pipeline Products & Ongoing Clinical Trials Overview
Table 45: Lumipulse G - AFP Assay - Product Status
Table 46: Lumipulse G - AFP Assay - Product Description
Table 47: Lumipulse G1200 - AMH - Product Status
Table 48: Lumipulse G1200 - AMH - Product Description
Table 49: Lumipulse G1200 - Estradiol Assay - Product Status
Table 50: Lumipulse G1200 - Estradiol Assay - Product Description
Table 51: Lumipulse G1200 - FSH Test - Product Status
Table 52: Lumipulse G1200 - FSH Test - Product Description
Table 53: Lumipulse G1200 - Progestrone Test - Product Status
Table 54: Lumipulse G1200 - Progestrone Test - Product Description
Table 55: Lumipulse G1200 - Testosterone Assay - Product Status
Table 56: Lumipulse G1200 - Testosterone Assay - Product Description
Table 57: Lumipulse G1200 - Total ß-HCG Assay - Product Status
Table 58: Lumipulse G1200 - Total ß-HCG Assay - Product Description
Table 59: Genovum Sp. z o.o. Pipeline Products & Ongoing Clinical Trials Overview
Table 60: Diagnostic Test - Polycystic Ovarian Syndrome - Product Status
Table 61: Diagnostic Test - Polycystic Ovarian Syndrome - Product Description
Table 62: Hebrew University of Jerusalem Pipeline Products & Ongoing Clinical Trials Overview
Table 63: Diagnostic Assay - Ovulation - Product Status
Table 64: Diagnostic Assay - Ovulation - Product Description
Table 65: Diagnostic Assay - Pregnancy - Product Status
Table 66: Diagnostic Assay - Pregnancy - Product Description
Table 67: Immunodiagnostic Systems Holdings plc Pipeline Products & Ongoing Clinical Trials Overview
Table 68: IDS-iSYS - 17-beta Estradiol Assay - Product Status
Table 69: IDS-iSYS - 17-beta Estradiol Assay - Product Description
Table 70: IDS-iSYS - Total Testosterone Assay - Product Status
Table 71: IDS-iSYS - Total Testosterone Assay - Product Description
Table 72: IDS-iSYS Free Testosterone Assay - Product Status
Table 73: IDS-iSYS Free Testosterone Assay - Product Description
Table 74: King's College London Pipeline Products & Ongoing Clinical Trials Overview
Table 75: Elafin Test - Preterm Birth - Product Status
Table 76: Elafin Test - Preterm Birth - Product Description
Table 77: Labsystems Diagnostics Oy Pipeline Products & Ongoing Clinical Trials Overview
Table 78: Fluoro Enzymatic Immuno Assay - Neonatal 17-OH-Progesterone FEIA - Product Status
Table 79: Fluoro Enzymatic Immuno Assay - Neonatal 17-OH-Progesterone FEIA - Product Description
Table 80: Lucine Biotechnology, Inc. Pipeline Products & Ongoing Clinical Trials Overview
Table 81: Salivary Diagnostic Test - PCOS - Product Status
Table 82: Salivary Diagnostic Test - PCOS - Product Description
Table 83: Mindray Medical International Ltd Pipeline Products & Ongoing Clinical Trials Overview
Table 84: CL-2000i - DHEA-S Test - Product Status
Table 85: CL-2000i - DHEA-S Test - Product Description
Table 86: Northwestern University Pipeline Products & Ongoing Clinical Trials Overview
Table 87: At Home Menopause Test - Product Status
Table 88: At Home Menopause Test - Product Description
Table 89: Female Fertility Test - Product Status
Table 90: Female Fertility Test - Product Description
Table 91: Oasis Diagnostics Corp Pipeline Products & Ongoing Clinical Trials Overview
Table 92: VerOFy Salivary Based Test - Estradiol - Product Status
Table 93: VerOFy Salivary Based Test - Estradiol - Product Description
Table 94: Orangelife Pipeline Products & Ongoing Clinical Trials Overview
Table 95: Pregnancy Kit - Product Status
Table 96: Pregnancy Kit - Product Description
Table 97: Paramedical Srl Pipeline Products & Ongoing Clinical Trials Overview
Table 98: PKL PPC 960 - AMH - Product Status
Table 99: PKL PPC 960 - AMH - Product Description
Table 100: PKL PPC 960 - Inhibin A - Product Status
Table 101: PKL PPC 960 - Inhibin A - Product Description
Table 102: PerkinElmer Inc Pipeline Products & Ongoing Clinical Trials Overview
Table 103: Diagnostic Test - Preterm Birth - Product Status
Table 104: Diagnostic Test - Preterm Birth - Product Description
Table 105: Proteomika Pipeline Products & Ongoing Clinical Trials Overview
Table 106: Proimplant - Product Status
Table 107: Proimplant - Product Description
Table 108: QuickCheck Health Inc Pipeline Products & Ongoing Clinical Trials Overview
Table 109: Diagnostic Test - Pregnancy - Product Status
1.2 List of Figures
Figure 1: Reproductive Hormones and Proteins Tests - Pipeline Products by Stage of Development
Figure 2: Reproductive Hormones and Proteins Tests - Pipeline Products by Segment
Figure 3: Reproductive Hormones and Proteins Tests - Pipeline Products by Territory
Figure 4: Reproductive Hormones and Proteins Tests - Pipeline Products by Regulatory Path
Figure 5: Reproductive Hormones and Proteins Tests - Pipeline Products by Estimated Approval Date

Download our eBook: How to Succeed Using Market Research

Learn how to effectively navigate the market research process to help guide your organization on the journey to success.

Download eBook

Share this report